4//SEC Filing
CYTRX CORP 4
Accession 0001140361-16-090197
$LADXCIK 0000799698operating
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 2:27 PM ET
Size
5.4 KB
Accession
0001140361-16-090197
Insider Transaction Report
Form 4
CYTRX CORPCYTR
Wieland Douglas Scott
Sr. VP - Drug Development
Transactions
- Award
Stock Option (right to buy)
2016-12-15+150,000→ 150,000 totalExercise: $0.43Exp: 2026-12-14→ CytRx Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The stock option vests monthly for 36 months in equal installments, beginning 15 January 2017, provided Reporting Person remains in continuous employ of Issuer, or the conditions for immediate vesting do not occur.
Documents
Issuer
CYTRX CORP
CIK 0000799698
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000799698
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 2:27 PM ET
- Size
- 5.4 KB